The Use of Bionic Prodrugs for the Enhancement of Low Dose Radiotherapy

Xiurong Sun, Fangming Su, Xin Luo, Yingxia Ning

Open source

DOI
10.3389/fchem.2021.710250
Published
2021-08-11
Container
Frontiers in Chemistry
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fchem.2021.710250,
  title = {The Use of Bionic Prodrugs for the Enhancement of Low Dose Radiotherapy},
  author = {Xiurong Sun and Fangming Su and Xin Luo and Yingxia Ning},
  year = {2021},
  journal = {Frontiers in Chemistry},
  doi = {10.3389/fchem.2021.710250},
  url = {https://doi.org/10.3389/fchem.2021.710250}
}

RIS

TY  - JOUR
TI  - The Use of Bionic Prodrugs for the Enhancement of Low Dose Radiotherapy
AU  - Xiurong Sun
AU  - Fangming Su
AU  - Xin Luo
AU  - Yingxia Ning
PY  - 2021
JO  - Frontiers in Chemistry
DO  - 10.3389/fchem.2021.710250
UR  - https://doi.org/10.3389/fchem.2021.710250
ER  - 

APA

Sun, X., Su, F., Luo, X., & Ning, Y. (2021). The Use of Bionic Prodrugs for the Enhancement of Low Dose Radiotherapy. Frontiers in Chemistry. https://doi.org/10.3389/fchem.2021.710250

Source records